Trial no.:
|
PACTR202206548559545 |
Date of Approval:
|
15/06/2022 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Ultrasound guided maxillary nerve block for perioperative pain management for patients undergoing endoscopic sinus surgery: Randomized control trial |
Official scientific title |
Ultrasound guided maxillary nerve block for perioperative pain management for patients undergoing endoscopic sinus surgery: Randomized control trial
|
Brief summary describing the background
and objectives of the trial
|
Functional endoscopic sinus surgery (FESS) is known to be a treatment of choice in cases nasal polyps, chronic inflammatory para-nasal sinus diseases and chronic rhino-sinusitis. Patients undergoing FESS liable for an unanticipated overnight hospital admission, and for early hospital readmission due to nasal bleeding, pain, or intolerance of nasal packing or dressing. Challengeable aspects facing the anesthesiologist during FESS are airway management considerations for facilitating surgical access and safe emergence from anesthesia, without associated bucking or straining to prevent laryngospasm, and also minimize post-extubation hypertensive responses and resulting profuse microvascular bleeding. Adequate postoperative analgesia for different levels of pain potentially decreases inflammatory cytokines released as a result of pain, leading to diminished subsequent analgesic requirements. Furthermore, improvement of immediate postoperative pain to minimize discomfort and obtain patient satisfaction. Multimodal analgesia can help to keep opioid use to a minimum and provide effective pain control through the use of the regional nerve blocks. Regional anesthesia for maxillofacial surgery has been reported to reduce intraoperative stress responses and perioperative opioid consumption, providing a better and more safe anesthesia technique. The maxillary nerve (MN) block was first described in the early 20th century for dental purposes. It has recently been prescribed for various indications, as cleft palate surgery, oral and orthognathic surgery and maxillary bone fractures. The ultrasound guided suprazygomatic approach at the level of the suprazygomatic angle has been suggested as the safest, easiest, and most reliable approach to the pterygopalatine fossa ( PPF) for the MN block. It prevents penetration of the base of the skull and the orbit, and the bony landmarks are more superficial and more easily palpated which simplifies block performance and improve |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia,Ear, Nose and Throat |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Prevention |
Anticipated trial start date |
20/06/2022 |
Actual trial start date |
|
Anticipated date of last follow up |
19/09/2022 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
60 |
Actual target sample size (number of participants) |
|
Recruitment status |
Not yet recruiting |
Publication URL |
N/A |
|